The invention provides an L-
threonine aldolase
mutant, the
amino acid sequence of the L-
threonine aldolase
mutant is obtained by mutating
wild type L-
threonine aldolase as shown in SEQ ID NO.1, and the mutations comprise at least one
mutation of amino acids at the 185th site, the 198th site, the 281 site, the 8th site, the 142 site and the 171th site of the SEQ ID NO.1. The invention also provides an application of the
mutant as a catalyst in synthesis of (2S, 3R)-2-amino-3-hydroxy-3-(4-methylsulfonyl phenyl) propionic acid. Compared with other biocatalysts, the L-
threonine aldolase mutant disclosed by the invention is high in catalytic activity and high in yield, meets the requirement that the de value is as high as 99%, has the advantages of high
atom economy, high product optical purity, mild
reaction conditions, environment friendliness, simple product post-treatment and the like, and is a (2S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S, 3S The method is one of the most ideal reactions for synthesizing (3R, 3R)-2-amino-3-hydroxy-3-(4-methylsulfonyl phenyl) propionic acid.